Yin Yang 1‐mediated epigenetic silencing of tumour‐suppressive microRNAs activates nuclear factor‐κB in hepatocellular carcinomaDaisy PF Tsang, Alfred S.L. Cheng, William Ka Kei Wu et al.|The Journal of Pathology|2016Cited by 60
[Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: a case report and literature review].Peipei Xu, B Chen, Yang Du et al.|PubMed|2024Cited by 1